G.P.13.05 The diagnosis and management of Duchenne muscular dystrophy: Internationally generated care recommendations
K. Bushby(Newcastle University), Carolyn M. Constantin(Centers for Disease Control and Prevention), David J. Birnkrant(MetroHealth Medical Center), Linda Cripe(The Ohio State University), Laura E. Case, Craig M. McDonald(University of California, Davis), Ajay Kaul(Cincinnati Children's Hospital Medical Center), Richard S. Finkel(Nemours Children's Clinic), Paula R. Clemens(Veterans Health Administration), S. Pandya(Strong Memorial Hospital), F. Shapiro, Kathi Kinnett(Cincinnati Children's Hospital Medical Center), Jean Tomezsko(Children's Hospital of Philadelphia), James Poysky(Baylor College of Medicine)
Cited by 1
Related Papers
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
|The Lancet Neurology|2009|2k
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
|The Lancet Neurology|2009|1.2k
Agalsidase-Beta Therapy for Advanced Fabry Disease
|Annals of Internal Medicine|2007|565
Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy
|New England Journal of Medicine|1989|518